CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-22 | Muzzey Dale Chief Scientific Officer | Shares withheld for taxes | −1,399 | $22.91 | $32K | 69,772 |
| 2023-03-22 | Wong Pamela Chief Legal Officer | Shares withheld for taxes | −1,432 | $22.91 | $33K | 72,320 |
| 2023-03-22 | Haas Kevin Richard Chief Technology Officer | Shares withheld for taxes | −1,677 | $22.91 | $38K | 111,065 |
| 2023-03-22 | Verratti Mark Chief Commercial Officer | Shares withheld for taxes | −1,351 | $22.91 | $31K | 266,076 |
| 2023-03-22 | Lambert Nicole Chief Operating Officer | Shares withheld for taxes | −2,419 | $22.91 | $55K | 252,206 |
| 2023-03-22 | Riggsbee Richard Bryan Chief Financial Officer | Shares withheld for taxes | −4,074 | $22.91 | $93K | 377,594 |
Page 15 of 15 · 286 trades